pCMV6-Entry IL36RN Κ35R Citations (1)
Originally described in: In Silico and In Vitro Analysis of IL36RN Alterations Reveals Critical Residues for the Function of the Interleukin-36 Receptor Complex.Hassi NK, Weston T, Rinaldi G, Ng JC, Smahi A, Twelves S, Davan-Wetton C, Fakhreddine D, Fraternali F, Capon F J Invest Dermatol. 2023 Dec;143(12):2468-2475.e6. doi: 10.1016/j.jid.2023.06.191. Epub 2023 Jul 4. PubMed Journal
Articles Citing pCMV6-Entry IL36RN Κ35R
| Articles |
|---|
| BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer. Zhang Y, Fang M, Li S, Xu H, Ren J, Tu L, Zuo B, Yao W, Liang G. Mol Cancer. 2022 Aug 2;21(1):158. doi: 10.1186/s12943-022-01621-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.